Chester County News and Community Website
SUZHOU, China and NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. announced a strategic collaboration with Jiangsu Alphamab Biopharmaceuticals Co., Ltd. (“Alphamab”) to develop and commercialize novel antibody drug conjugates (ADCs) …
ArriVent BioPharma Partners with Alphamab to Develop Cutting-Edge Cancer Treatments Read More
PHILADELPHIA PA — Greater Philadelphia has emerged as a powerhouse in the cell and gene therapy industry, housing almost 10 percent of the world’s companies in this rapidly expanding sector. …
Greater Philadelphia Dominates Cell and Gene Therapy Landscape – A Beacon of Innovation and Employment Read More
PHILADELPHIA, PA — Hepatocellular carcinoma (HCC), better known as liver cancer, is a particularly aggressive form of cancer that often leaves healthcare providers grappling for treatment options. This cancer’s stealthy …
Novel Vaccine Shows Promising Results in Battle Against Liver Cancer: A New Hope in the Medical Field Read More
MALVERN, PA — In a significant advancement for retinitis pigmentosa (RP) treatment, Ocugen, Inc. (NASDAQ: OCGN) has received favorable scientific advice from the European Medicines Agency (EMA) regarding its pivotal …
Ocugen’s Gene Therapy OCU400 Moves Closer to European Market with EMA’s Positive Opinion Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focusing on discovering, developing, and commercializing transformative therapies to cure blindness diseases, announced a significant milestone in its Phase 1/2 …
Ocugen Advances in Pioneering Gene Therapy for Geographic Atrophy with DSMB Approval to Proceed to Medium Dose in Clinical Trial Read More
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has granted equity awards to 30 new hires under its 2023 Inducement Plan, as a key part of the employment package designed …
Madrigal Pharmaceuticals Awards Equity to New Employees as Inducement Read More MALVERN, PA — Ocugen Inc. (NASDAQ: OCGN released its general business update on Tuesday, revealing promising strides in the pursuit of transformative treatments for blindness diseases. The Pennsylvania-based company’s dedication …
Ocugen Inc. Embarks on A Game-Changing Era With Revolutionary Gene Therapy Initiatives Read More
BERWYN, PA — AscellaHealth has released its latest edition of the Specialty & Rare Pipeline Digest™. This quarterly digital publication stands as the industry’s most detailed resource on imminent specialty …
AscellaHealth Unveils Quarter’s Insights on Specialty and Rare Disease Drug Developments Read More
BRISTOL, PA — Abzena has unveiled a $5 million investment to enhance its Bristol, Pennsylvania facility, specializing in bioconjugate development and cGMP (current Good Manufacturing Practice) manufacturing. This substantial financial …
Abzena Amplifies Bioconjugate Development and Manufacturing with $5 Million Bristol Site Expansion Read More
PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO), a pioneer in the development of DNA medicines for treating and preventing diseases, has announced its participation in the upcoming Citizens JMP Novel …
INOVIO’s Leadership to Spotlight Innovative Disease-Fighting Technologies at Citizens JMP Novel Therapeutics Forum Read More